Belgian IT Stock News

Aedifica/SA (ENXTBR:AED) just released its full year 2025 results, reporting €360.95 million in sales, €244.43 million in net income and confirming a proposed €4.00 per share gross dividend for May 2026. See our latest analysis for Aedifica/SA. The latest figures and confirmed €4.00 dividend proposal come after a period of strong momentum, with a 90 day share price return of 18.27% and a 1 year total shareholder return of 32.20% from a €78.65 share price starting point. If this earnings...

Interest in Syensqo (ENXTBR:SYENS) has picked up after the company reported 4% full year net sales growth in Composite Materials and exited its Oil & Gas unit, sharpening its focus as a pure play specialty company. See our latest analysis for Syensqo. That sharper focus has not yet shown up in the price, with the share price at €48.37 and recent momentum clearly weak, including a 7 day share price return of 37.94% decline and a 1 year total shareholder return of 30.03% decline. If Syensqo’s...

How Anheuser-Busch InBev’s Recent Performance Is Catching Investor Attention Anheuser-Busch InBev (ENXTBR:ABI) has drawn fresh interest after a recent run of positive returns, with the share price showing gains over the past week, month, past 3 months, and year to date. See our latest analysis for Anheuser-Busch InBev. That recent momentum, with a 30 day share price return of 17.20% and 90 day share price return of 29.80% taking the share price to €68.82, sits alongside a 1 year total...

Cmb.Tech (ENXTBR:CMBT) has just posted its FY 2025 numbers, with fourth quarter revenue of US$590.5 million and basic EPS of US$0.31, while trailing 12 month revenue came in at about US$1.9 billion alongside basic EPS of US$0.70. Over recent periods, the company has seen revenue move from US$226.0 million and basic EPS of US$0.48 in Q4 2024 to US$590.5 million and US$0.31 in Q4 2025. This gives investors a clear set of markers to track how the earnings story is evolving. With trailing net...

ageas (ENXTBR:AGS) is back in focus after proposing a total gross cash dividend of €3.75 per share for 2025, a 7% increase compared with 2024, following a year of significant corporate changes. See our latest analysis for ageas. The proposed higher dividend comes after a period where momentum in ageas shares has been building, with a 30-day share price return of 9.0% and a 1-year total shareholder return of 24.32% supported by its transformational deals and repositioning in core insurance...

If you are wondering whether argenx is still worth your attention at current prices, a key question is how its market value compares with its fundamentals. The share price last closed at €652.00, with returns of 6.6% over 1 year, 100.3% over 3 years, and 157.7% over 5 years. More recently, it has seen a 9.1% decline over 7 days, 11.0% over 30 days, and 9.9% year to date. Recent news around argenx has focused on its position in the pharmaceuticals and biotech space and investor interest in...

Solvay (ENXTBR:SOLB) has wrapped up FY 2025 with fourth quarter revenue of €1.1b and a basic EPS loss of €0.90, capping a year in which trailing twelve month EPS came in at €0.29 on revenue of €4.7b. Over the past few quarters, the company has seen quarterly revenue move from €1.24b in Q1 2025 to €1.09b in Q4 2025, while basic EPS ranged from €0.78 in Q1 to a loss of €0.90 in Q4. This presents a picture where thin margins and that final quarter loss sit alongside expectations for stronger...

Event context and recent share performance With no single headline event driving attention today, NV Bekaert (ENXTBR:BEKB) is attracting interest as investors reassess the stock after a month and past 3 months of double digit total returns. See our latest analysis for NV Bekaert. The recent 9.95% 1 month share price return and 20.60% 3 month share price return, alongside a 34.09% 1 year total shareholder return, point to building momentum as investors reassess NV Bekaert at around €44.2 per...

Recent performance snapshot argenx (ENXTBR:ARGX) has seen mixed share performance recently, with a small move over the past week, a modest gain over the past month, and a double digit decline across the past 3 months. Over a longer horizon, argenx shows a positive year to date return and a higher 1 year total return, while the 3 year and 5 year total returns are considerably above its shorter term moves. See our latest analysis for argenx. At a share price of €710.2, argenx’s recent 10.19% 3...

Earnings and dividend announcement set the tone Gimv (ENXTBR:GIMB) has drawn fresh attention after reporting net income of €173.31 million for the nine months to December 31, 2025, and confirming an annual dividend of €1.3650 per share. See our latest analysis for Gimv. The earnings release and dividend confirmation appear to have fed into a positive trend, with Gimv’s 1-day share price return of 1.95% and 7-day share price return of 4.32% lifting the share price to €47.1. The 1-year total...

Wondering if Solvay at €27.88 is offering good value right now, or if the best days are already priced in? This article breaks down what the current share price might be telling you. Over the short term the stock has returned 0.9% in the last 7 days and 7.1% over the past month. The year to date return sits at 2.0% and the 1 year return shows a 4.0% decline, compared with a 3 year return of 50.0% and 5 year return of 63.7%. Recent attention around Solvay has largely focused on how investors...

Why Sipef (ENXTBR:SIP) Is On Investors’ Radar After Its 2025 Earnings Sipef (ENXTBR:SIP) has drawn fresh attention after reporting full year 2025 sales of US$570.43 million and net income of US$125.45 million, alongside basic EPS from continuing operations of US$12.05. See our latest analysis for Sipef. That earnings release comes after a strong run in the shares, with the €88.4 latest share price sitting on a 30 day share price return of 4.74% and a 1 year total shareholder return of 53.64%...

Vastned (ENXTBR:VASTB) FY 2025 earnings snapshot Vastned (ENXTBR:VASTB) has reported fresh numbers for FY 2025, with first half revenue of €33.7 million and basic EPS of €1.62, setting the tone for how investors may view the rest of the year. The company’s revenue moved from €9.6 million and EPS of €1.71 in the first half of 2024 to €9.2 million and EPS of €0.39 in the second half of 2024, before rising to the current €33.7 million and €1.62 EPS in the latest half. These swings form the...

Anheuser-Busch InBev SA/NV recently reported past fourth-quarter 2025 results, with sales of US$15,555 million and net income of US$1,959 million, and its board proposed a final dividend of €1.00 per share for 2025, pending shareholder approval at the April 29, 2026 AGM. Alongside stronger quarterly earnings, the company completed a US$635 million share buyback covering 9,731,300 shares, reinforcing its recent emphasis on returning cash to shareholders through both dividends and...

VGP (ENXTBR:VGP) has combined its latest annual earnings release with a proposed ordinary dividend increase. This pairing draws attention to how its 2025 profit figures and higher cash payout might influence investor sentiment. See our latest analysis for VGP. At a share price of €107.8, VGP has a 1-month share price return of 5.48% and a year to date share price return of 10.79%. The 1-year total shareholder return of 37.89% contrasts with a 5-year total shareholder return decline of 10.25%,...

Why Umicore (ENXTBR:UMI) is on investors’ radar today Umicore (ENXTBR:UMI) has drawn fresh attention after recent share price swings, with the stock showing a negative 1 day move and a larger decline over the past month, despite a positive performance over the past 3 months. See our latest analysis for Umicore. At a share price of €18.31, Umicore’s recent 1 month share price return of a 10.07% decline contrasts with a stronger 3 month share price return of 26.10%. The 1 year total shareholder...

As European markets experience volatility amid global economic shifts, the pan-European STOXX Europe 600 Index recently hit a new high but ended the week with only a slight gain of 0.09%. This backdrop of fluctuating investor sentiment and economic expansion in key regions like the eurozone presents an intriguing environment for uncovering lesser-known stocks that might offer unique opportunities. In such conditions, identifying stocks with strong fundamentals and potential resilience to...

Cmb.Tech (ENXTBR:CMBT) has agreed to sell two VLCCs, Ingrid and Ilma. The transaction is expected to generate an approximate US$98.2 million capital gain recorded in the second quarter of 2026. See our latest analysis for Cmb.Tech. The vessel sale headlines arrive as Cmb.Tech's share price trades at €11.22, with a 30-day share price return of 11.53% and a 90-day share price return of 33.57%. The 1-year total shareholder return of 17.80% sits against a 5-year total shareholder return of...

If you are wondering whether SCR-Sibelco is priced fairly today, you are not alone. The stock often attracts attention from investors trying to work out if they might be overpaying or missing an opportunity. Over the short term, the share price has been mixed, with a 1.3% return over the last 7 days, a 0.8% decline over 30 days, and returns of 12.7% decline year to date and 5.7% decline over the past year, extending to a 10.9% decline over five years. Recent news coverage has mainly focused...

Key Insights Significant control over Biotalys by private equity firms implies that the general public has more power...

As European markets experience volatility amid global concerns over AI disruption, the pan-European STOXX Europe 600 Index managed to hit a new high, ending the week with a slight gain. In such an environment, dividend stocks can offer investors a degree of stability and income potential, making them attractive options for those looking to navigate uncertain market conditions.

It's been a good week for Anheuser-Busch InBev SA/NV ( EBR:ABI ) shareholders, because the company has just released...

Shareholders might have noticed that KBC Group NV ( EBR:KBC ) filed its yearly result this time last week. The early...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...